Clinuvel Pharmaceuticals (CUV AU)

147

Analysis

Health Care • Australia

Clinuvel Pharmaceuticals Limited is an Australian biopharmaceutical company. The company focused on developing dermatology pharmaceutical products for a range of UV-related skin disorders. Clinuvel's work aims at preventing the symptoms of diseases related to harmful UV radiation.

Refresh

Exchange Announcement • 15 Oct 2026 05:18

Notification of cessation of securities - CUV

Exchange Announcement • 06 Oct 2026 05:54

Section 708A Cleansing Statement

Exchange Announcement • 06 Oct 2026 05:53

Notification of cessation of securities - CUV

Exchange Announcement • 06 Oct 2026 05:51

Application for quotation of securities - CUV

Exchange Announcement • 06 Oct 2026 05:17

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Notification of cessation of securities - CUV

Section 708A Cleansing Statement

Notification of cessation of securities - CUV

Application for quotation of securities - CUV

Change in substantial holding